Mitochondrial encoded NADH dehydrogenase 5 (MT-ND5) gene point mutation presents as late onset cardiomyopathy
Authors:
- Nir AyalonNANir Ayalon
- Leigh Anne FloreLFLeigh Anne Flore
- Thomas G. ChristensenTCThomas G. Christensen
- Flora SamFSFlora Sam
- 1 September 2013
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 167 (5) , e143-e145
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Mitochondrial respiratory control and early defects of oxidative phosphorylation in the failing human heartThe International Journal of Biochemistry & Cell Biology, 2011
- NOVEL MITOCHONDRIAL DNA MUTATIONS ASSOCIATED WITH CHINESE FAMILIAL HYPERTROPHIC CARDIOMYOPATHYClinical and Experimental Pharmacology and Physiology, 2009
- Mutation of Mitochondrial DNA G13513A Presenting with Leigh Syndrome, Wolff-Parkinson-White Syndrome and CardiomyopathyPediatrics & Neonatology, 2008
- The mitochondrial 13513G>A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscleMolecular Genetics and Metabolism, 2008
- Clinical and molecular findings in children with complex I deficiencyBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2004
- Mitochondrial myopathy and cardiomyopathy in siblingsPediatric Neurology, 1989
- Deficiency of the reduced nicotinamide adenine dinucleotide dehydrogenase component of complex I of mitochondrial electron transport. Fatal infantile lactic acidosis and hypermetabolism with skeletal-cardiac myopathy and encephalopathy.Journal of Clinical Investigation, 1987